Key result
Impella CP-supported multivessel PCI improves LVEF to ~30% in cardiogenic shock.
Why the study?
Cardiogenic shock complicating acute myocardial infarction carries high mortality, and while Impella CP support facilitates complex high-risk PCI, it carries excess bleeding risk and demands careful patient selection.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Supports Impella-assisted multivessel PCI feasibility in NSTEMI shock; leaves open efficacy pending randomized trials.
Cardiogenic shock (CS) is a severe complication of acute myocardial infarction
No takes yet. Share an insight, caveat, or question.
Manikowska et al. (2026) conducted a case report in Non-ST segment elevation myocardial infarction complicated by cardiogenic shock (n=1). Impella CP-supported multivessel percutaneous coronary intervention was evaluated on Left ventricular ejection fraction (LVEF) and clinical recovery at discharge. Impella CP-supported multivessel PCI in a 77-year-old male with NSTEMI and cardiogenic shock restored TIMI 3 flow and improved LVEF from 10%-15% to 30% at hospital discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: